Haematologica (Mar 2024)
Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up
- Elisa Jacobsen Pulczynski,
- Mikkel Runason Simonsen,
- Outi Kuittinen,
- Unn-Merete Fagerli,
- Martin Erlanson,
- Øystein Fluge,
- Sirpa Leppä,
- Bjørn Østenstad,
- Alexander Fosså,
- Mikael Eriksson,
- Tarec El-Galaly,
- Hanne Kuitunen,
- Karin Papworth,
- Maria Ljungqvist,
- Martin B. Pedersen,
- Marjukka Pollari
Affiliations
- Elisa Jacobsen Pulczynski
- Department of Haematology, Aarhus University Hospital, Aarhus, Denmark; Department of Haematology, Region Hospital Goedstrup, Herning
- Mikkel Runason Simonsen
- Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark; Department of Mathematical Sciences, Aalborg University, Aalborg
- Outi Kuittinen
- Department of Oncology, Kuopio University Hospital Cancer Center, Kuopio, Finland; Faculty of Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio
- Unn-Merete Fagerli
- Department of Oncology, St Olav University Hospital, Trondheim, Norway; Department of Clinical and Molecular Medicine, Norwegian University of science and technology (NTNU), Trondheim, Norway
- Martin Erlanson
- Department of Radiation Sciences, Umeå University, Umeå, Sweden
- Øystein Fluge
- Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway
- Sirpa Leppä
- Research Programs Unit/Applied Tumor Genomics Research Program, University of Helsinki, Helsinki, Finland; Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki
- Bjørn Østenstad
- Department of Oncology, Oslo University Hospital, Oslo, Norway
- Alexander Fosså
- Department of Oncology, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for B-cell Malignancies, University of Oslo, Oslo, Norway
- Mikael Eriksson
- Department of Oncology, Skane University Hospital, Lund, Sweden; Medical Oncology, Lund University, Lund, Sweden
- Tarec El-Galaly
- Department of Hematology, Aalborg University Hospital, Aalborg
- Hanne Kuitunen
- Cancer Centre, Oulu University Hospital, Oulu
- Karin Papworth
- Department of Radiation Sciences, Umeå University, Umeå, Sweden
- Maria Ljungqvist
- Department of Clinical Science and Education, Södersjukhuste, Karolinska Insitutet, Stockholm, Sweden; Haematology Centre, Karolinska University Hospital, Stockholm, Sweden
- Martin B. Pedersen
- Department of Haematology, Aarhus University Hospital, Aarhus
- Marjukka Pollari
- Research Programs Unit/Applied Tumor Genomics Research Program, University of Helsinki, Helsinki, Finland; Department of Oncology, Tays Cancer Center, Tampere University Hospital, Tampere
- DOI
- https://doi.org/10.3324/haematol.2024.285207
- Journal volume & issue
-
Vol. 999,
no. 1
Abstract
Not available.
